medigraphic.com
Instituto Nacional de Salud Pública

2006, Number 3

<< Back Next >>

salud publica mex 2006; 48 (3)

Cervical cancer and the HPV link:Identifying areas for education in Mexico City’spublic hospitals

Aldrich T, Landis S, García SG, Becker D, Sanhueza P, Higuera A

Language: English
References: 12
Page: 236-246
PDF size: 94.15 Kb.


ABSTRACT

Objective. To assess Mexico City physicians’ knowledge andpractices regarding cervical cancer and human papillomavirus (HPV) to compare obstetricians/gynecologists (ob/gyns)and general practitioners (GPs) on these variables. Material and Methods. In April 2003, 187 ob/gyns and GPs work-ing in 15 hospitals affiliated with the Federal District Secretaryof Health (SSDF) completed a self-administered questionnaire. Pearson’s chisquare tests were used to compare ob/gyns and GPs on outcome variables. Results. Nearly all providers (93%) identified HPV as the principal cause of cervicalcancer. Ob/gyns had more detailed knowledge about HPV than GPs and were more likely to have heard of commononcogenic strains (p=.000). Sixteen percent of all physiciansincorrectly stated that Pap tests should be performed everysix months regardless of previous results, and 17% recommended hysterectomy as an option for treating mild or mod-erate dysplasia. Conclusions. While SSDF physicians had basicknowledge about the cervical cancer-HPV link, screening andmanagement norms are priority areas for educational interventions.


REFERENCES

  1. World Health Organization, http://www.who.int/en/. [Accessed 2003,August 7].

  2. Blumenthal PD, Ringers P, McIntosh N, Graffikin L. Innovativeapproaches to cervical cancer prevention. Medscape Womens Health2001;6:1.

  3. Flores Y, Keerti S, Lazcano-Ponce E, Hernandez M, Bishai D, Ferris DGet al. Design and methods of the evaluation of an HPV-based cervicalcancer screening strategy in Mexico: The Morelos HPV Study. SaludPublica Mex 2002;44:335-344.

  4. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relationbetween human papillomavirus and cervical cancer. J Clin Pathol2002;55:244-265.

  5. Lai KQ, Nguyen TT, Mock J, McPhee SJ, Doan HT, Pham TH. IncreasingVietnamese-American physicians’ knowledge of cervical cancer and Paptesting: impact of continuing medical education programs. Ethn Dis2004; 14(3 Suppl 1):S122-S127.

  6. Ajayo IO, Adewole IF. Breast and cervical cancer screening activitiesamong family physicians in Nigeria. Afr J Med Med Sci 2002;31(4):305-309.

  7. Arillo-Santillan E, Lazcano-Ponce E, Peris M, Salazar-Martinez E,Salmeron-Castro J, Alonso-De Ruiz P. Knowledge of health professionalsabout the prevention of cancer of the cervix: alternatives to medicaleducation. Salud Publica Mex 2000;42:34-42.

  8. Aldrich T, Becker D, García SG, Lara D. Mexican physicians’ knowledgeand attitudes about the human papillomavirus and cervical cancer: Anational survey. Sex Transm Infect 2005;81(2):135-141.

  9. Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality ofcervical cancer in Latin America. Salud Publica Mex 2003; 45(Suppl3):S306-S314.

  10. Programa de Acción: Cáncer Cérvico Uterino. México: Secretaría deSalud, 2002.

  11. Lazcano-Ponce EC, Rivera L, Arillo-Santillan E, Salmeron J.Acceptability of a human papillomavirus trial vaccine among mothers ofadolescents in Cuernavaca, Mexico. Arch Med Res 2001; 32:243-247.

  12. Flores Y, Bishai D, Lazcano E, Shah K, Lorincz A, Hernandez M.Improving cervical cancer screening in Mexico: results from theMorelos HPV Study. Salud Publica Mex 2003; 45(Suppl 3):S388-S398.




2020     |     www.medigraphic.com